Author

Sham Rampersaud

University of California, San FranciscoORCID 0000-0001-7473-4144Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Arun P. WiitaiD· 3 shared Veronica SteriiD· 3 shared Abhilash BarpandaiD· 2 shared Amrik S. KangiD· 2 shared Bonell Patiño-EscobariD· 2 shared Corynn KasapiD· 2 shared Fernando Salangsang· 2 shared Huimin GengiD· 2 shared

Activity by Year

2022-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Arun P. WiitaORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 12, 2026

Integrative Genomic, Single-Cell, and Functional Profiling of the CD48-CD244 Axis and NK-Cell Dysfunction in Multiple Myeloma

Bonell Patiño-Escobar, Torsten Steinbrunn, Lucy Maritza Pérez Lugo…·Arun P. Wiita

The paper investigates the CD48-CD244 axis in multiple myeloma, showing CD48 enhances NK-cell activation but contributes to NK exhaustion and poor prognosis.

DOI 10.64898/2026.05.08.723909

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 21, 2025

Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-Beta2

Anju Wadhwa, Haley E. Johnson, Kondapa Naidu Bobba…·Robert R. Flavell

This study demonstrates promising preclinical efficacy of aITGB2-targeted radiotheranostics for selective imaging and therapy in AML.

DOI 10.1101/2025.08.21.671206

humanimaging

𝕏 PostBluesky

Cancer BiologyBloodPeer-reviewedMay 13, 2025

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar…·Arun P. Wiita

Structure-optimized CD27-based CAR-T cells targeting CD70 show >80-fold improved expansion in vivo and offer a potential therapy for high-risk multiple myeloma patients.

31 citationstop 1%

humanproteomics

𝕏 PostBluesky

BioinformaticsbioRxivPreprintNov 21, 2022

Starfysh reveals heterogeneous spatial dynamics in the breast tumor microenvironment

Siyu He, Yinuo Jin, Achille Nazaret…·Elham Azizi

Starfysh integrates spatial transcriptomics and histology to analyze tumor microenvironments, identifying disease-specific spatial hubs and immune interactions in breast cancers.

7 citations

humanspatial transcriptomics

𝕏 PostBluesky